impaired working memory in patients with mild disabled relapsing-remitting multiple sclerosis and it’s relation with depression and fatigue

Authors
abstract

the multiple sclerosis (ms) is a chronic disease of cns leads to some dysfunctions including cognitive (working memory), mood (depression) and fatigue. in spite of previous investigations about working memory impairment in patients with ms, there are scare evidences for working memory dysfunction in mild disabled ms patients (edss

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

The Relationship Between Chronic Fatigue Syndrome and Depression: Mediating Roles of Executive Functions in Patients with Relapsing-Remitting Multiple Sclerosis

This study aimed to investigate the relationship between chronic fatigue syndrome (CFS) and depression with the mediating role of executive functions (EFs) in patients with relapsing-remitting multiple sclerosis (RRMS). The statistical population of this descriptive correlational study included all patients with RRMS who were referred to Tehran neurologists in the summer of 2021 and among them,...

full text

the past hospitalization and its association with suicide attempts and ideation in patients with mdd and comparison with bmd (depressed type) group

چکیده ندارد.

Comparing the Safety and Efficacy of Ziferon and Betaferon in Patients With Remitting-Relapsing Multiple Sclerosis

Background: The present study aimed to compare the clinical efficacy and safety profile of Ziferon and Betaferon. Objectives: In total, 41 consecutive patients with relapsing forms of Multiple Sclerosis (MS) were selected from the MS outpatient clinic affiliated to Tehran University of Medical Sciences. The patients were randomly assigned into two groups. Methods: Each group either received Z...

full text

Safety and Efficacy of Fingolimod in Iranian Patients with Relapsing-remitting Multiple Sclerosis

Introduction: Fingolimod is the first confirmed oral immune-modulator to treat Relapsing-Remitting Multiple Sclerosis (RRMS). This study aimed to investigate the safety and efficacy of fingolimod therapy in Iranian patients with RRMS. Methods: In our trial, 50 patients resistant to conventional interferon therapy were assigned to receive fingolimod 0.5 mg per day for 12 months. The number of D...

full text

Working memory impairment in multiple sclerosis relapsing-remitting patients with episodic memory deficits.

Episodic memory is impaired in multiple sclerosis (MS) patients, possibly because of deficits in working memory (WM) functioning. If so, WM alterations should necessarily be found in patients with episodic memory deficits, but this has not yet been demonstrated. In this study we aimed at determining whether episodic memory deficits in relapsing-remitting MS are found in conjunction with impaire...

full text

Increased Expression of miR-202-3p in Patients with Relapsing-Remitting Multiple Sclerosis

Background and objectives: One of the latest studies in the genetics field is the evaluation of role of micro-RNAs as a biomarker for diagnosis of multiple sclerosis (MS), which is a demyelinating disease of the central nervous system (CNS) and emerges in the form of numerous small and large plaques in white matter in the brain and spinal cord. This disease could be associated with several comp...

full text

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023